bispecific ligand-drug conjugate CBP-1018

A bispecific ligand-drug conjugate targeting two as of yet undisclosed receptors and conjugated to an as of yet undisclosed cytotoxic agent, with potential antineoplastic activity. Upon administration of bispecific ligand-drug conjugate CBP-1018, the bispecific ligand moiety targets and binds to one or both of the two as of yet undisclosed receptors expressed in certain tumor types. After internalization of the agent, the cytotoxic moiety is released and kills the cancer cells expressing the receptor(s), through an as of yet unknown mechanism of action.